In the current study, Sm treatment was also associated with down-regulation of the mTOR pathway (Fig. 4b), in line with the role of TOR in the maintenance of T regulatory cells47 and the demonstrated reduction of these cells post-schistosomiasis therapy48. Here, RORC is linked to schistosomiasis.